Finepoint Capital LP Morphic Holding, Inc. Transaction History

Finepoint Capital LP

  • $347 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$19.95 - $31.0 $3.42 Million - $5.32 Million
171,500 Added 52.71%
496,856 $14.3 Million
Q3 2023

Nov 13, 2023
BUY
$21.33 - $59.42 $806,273 - $2.25 Million
37,800 Added 13.15%
325,356 $7.45 Million
Q2 2023

Aug 11, 2023
BUY
$34.33 - $62.11 $9.87 Million - $17.9 Million
287,556 New
287,556 $16.5 Million

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Finepoint Capital LP Portfolio

Follow Finepoint Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email